Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (501-510 of 635) with videos related to

Pageof 64
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinomaRoula Albadine, Mathieu Latour, Antoun Toubaji, et al.
The American Journal of Surgical Pathology|April 4, 2017
Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference RecommendationsClare Verrill, Asli Yilmaz, John R Srigley, et al.
International Journal of Surgical Pathology|May 12, 2023
Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell CarcinomasLaurence M Briski, Manju Aron, Jonathan I Epstein, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 6, 2022
Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing AnalysisChin-Chen Pan, Chih-En Tseng, Naoto Kuroda, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
The American Journal of Surgical Pathology|May 30, 2013
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation serviceWhitney M Green, Raluca Yonescu, Laura Morsberger, et al.
The Journal of Pathology|April 18, 2019
Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsFrancesca Khani, Sara E Wobker, Jessica L Hicks, et al.
Histopathology|October 18, 2016
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelSean R Williamson, Brett Delahunt, Cristina Magi-Galluzzi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2024
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a SubsetEzra G Baraban, Roy Elias, Ming-Tseh Lin, et al.
Urologic Oncology|September 18, 2023
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassificationClaire M de la Calle, Yuezhou Jing, Mufaddal M Mamawala, et al.
Pageof 64

Showing results (501-510 of 635) with videos related to

Sort By:
Pageof 64
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinomaRoula Albadine, Mathieu Latour, Antoun Toubaji, et al.
The American Journal of Surgical Pathology|April 4, 2017
Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference RecommendationsClare Verrill, Asli Yilmaz, John R Srigley, et al.
International Journal of Surgical Pathology|May 12, 2023
Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell CarcinomasLaurence M Briski, Manju Aron, Jonathan I Epstein, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 6, 2022
Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing AnalysisChin-Chen Pan, Chih-En Tseng, Naoto Kuroda, et al.
The Prostate|December 1, 2011
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomyEli Rosenbaum, Shahnaz Begum, Mariana Brait, et al.
The American Journal of Surgical Pathology|May 30, 2013
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation serviceWhitney M Green, Raluca Yonescu, Laura Morsberger, et al.
The Journal of Pathology|April 18, 2019
Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsFrancesca Khani, Sara E Wobker, Jessica L Hicks, et al.
Histopathology|October 18, 2016
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation PanelSean R Williamson, Brett Delahunt, Cristina Magi-Galluzzi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2024
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a SubsetEzra G Baraban, Roy Elias, Ming-Tseh Lin, et al.
Urologic Oncology|September 18, 2023
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassificationClaire M de la Calle, Yuezhou Jing, Mufaddal M Mamawala, et al.
Pageof 64